Klick Health, a global, independent commercialisation partner for life sciences, has acquired Oxford PharmaGenesis, a ...

Every year, ASCO arrives with a theme. Most quietly disappear into the background by the end of the opening session, ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans to deepen its collaboration with the US Food and Drug Administration (FDA) to enhance patient access to ...

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...

For pharma, its AI progress appears to be slowed by a methodical procession of AI adoption through a series of chicanes.

Women in Healthcare Leadership podcast series. Now on its fourth series, “Hear from Her” has established itself globally as ...

Patients who had received only one prior line of systemic therapy showed a stronger trend for overall survival and ...

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies ...

Pompe disease is a rare, progressive neuromuscular disease, with infantile onset being the most aggressive form ...

Zymeworks, a biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of ...

Oxford BioTherapeutics (OBT) has announced two clinical milestones from its long-running oncology collaboration with ...

AbbVie has announced it will acquire Apogee and its diverse pipeline of multiple clinical-stage candidates in development ...